Scientific and medical professionals
dedicated to clinical laboratory science.
Our Scientific Advisory Board includes Academic scientists from different European countries, playing a significant role as Executives, in many respected scientific societies around the world and cumulating several thousands of scientific publications in first-line journals in the field of musculoskeletal diseases.
About Us
Pr. Jean-Marc Kaufman
Chief Executive Officer
Jean-Marc Kaufman obtained his MD and PhD degrees at the Ghent University, Belgium and he was a senior postdoctoral research fellow at the University of Texas Medical School at Houston. He is board certified in Endocrinology and in Nuclear Medicine. In 1985 he joined the staff of the Ghent University Hospital; he headed the department of Endocrinology from 2003 to 2014 and the Laboratory for Hormonology from 1995 to 2014. He was appointed in 1993 professor of medicine at the Ghent University (1993) and is past chair of the university department of Internal Medicine (2010-2014). He is presently professor emeritus at the Ghent University where he is pursuing clinical and research activities. Main research interests are in the assessment, regulation and action of sex steroids with focus on their role in health, disease and aging in men, and inmetabolic bone diseases (in particular osteoporosis in men). He is (co)author of >300 publications in international peer reviewed journals.
Scientific Advisory Board
Pr. Cyrus Cooper
Cyrus Cooper is Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Epidemiology at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.
He leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. His key research contributions have been: 1) discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; 2) demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; 3) characterisation of the definition and incidence rates of vertebral fractures; 4) leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture.
He is President of the International Osteoporosis Foundation; Chair of the BHF Project Grants Committee; an emeritus NIHR Senior Investigator; and Associate Editor of Osteoporosis International. He has previously served as Chairman of the Scientific Advisors Committee, International Osteoporosis Foundation; Chairman, MRC Population Health Sciences Research Network; Chairman of the National Osteoporosis Society of Great Britain; past-President of the Bone Research Society of Great Britain; and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups. He has published extensively (over 850 research papers; hi=119) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass. In 2015, he was awarded an OBE for services to medical research.
He leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. His key research contributions have been: 1) discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; 2) demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; 3) characterisation of the definition and incidence rates of vertebral fractures; 4) leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture.
He is President of the International Osteoporosis Foundation; Chair of the BHF Project Grants Committee; an emeritus NIHR Senior Investigator; and Associate Editor of Osteoporosis International. He has previously served as Chairman of the Scientific Advisors Committee, International Osteoporosis Foundation; Chairman, MRC Population Health Sciences Research Network; Chairman of the National Osteoporosis Society of Great Britain; past-President of the Bone Research Society of Great Britain; and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups. He has published extensively (over 850 research papers; hi=119) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass. In 2015, he was awarded an OBE for services to medical research.
Pr. Jean-Yves Reginster
Jean-Yves Reginster M.D., Ph.D. is currently Outstanding Professor of Epidemiology, Public Health and Health Economics as well as Professor of Bioethics and Societal Medicine at the University of Liège where he also serves as the Honorary Chair of the Bone and Cartilage Metabolism Unit. He is the Director of the Department of Public Health, Epidemiology and Health Economics at the University of Liège and Director of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging. He is visiting Professor at the Prince Mutaib Chair for biomarkers of chronic diseases, Department of Biochemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. He is an active researcher who has authored more than 900 publications, mainly dedicated to the pathophysiology, epidemiology, health economics, clinical and translational aspects of osteoporosis, osteoarthritis, frailty and sarcopenia. Among his other professional activities, Professor Reginster is President of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Co-Founder and Board member of the International Osteoporosis Foundation (IOF), where he serves as President of the Committee of National Societies (CNS). He previously served as Adjunct Professor of Medicine at Georgetown University Medical Center, Washington DC, USA. He was the Belgian alternate member for the Efficacy Working Party at the Committee for Human Proprietary Medicines (CHMP) of the European Medicines Agency (EMA) where he acted as rapporteur/co-rapporteur for the guidelines for the registration of drugs to be used in the management of osteoporosis and osteoarthritis.
Pr. Etienne Cavalier
Etienne Cavalier was born in Liege (Belgium) in 1971. He graduated as Master in Pharmaceutical sciences in 1994 and Advanced Master in Clinical biology in 1999 from the University of Liege (Belgium), which allowed him to be recognized as a European Specialist in Laboratory Medicine (EuSpLM). In 2010, he obtained his PhD thesis at the University of Liege.
Etienne Cavalier is now Professor of Clinical Chemistry at the University of Liege and Head of the Department of Clinical Chemistry of the University Hospital of Liege (CHU de Liège).
His current research topics are bones markers, vitamin D, PTH, vascular calcification markers, markers of acute kidney diseases, glomerular filtration rate (estimation, biomarkers), markers of frailty and sarcopenia, LCMS/MS methods for steroids and peptides quantification.
Etienne Cavalier is the actual President of the Royal Belgian Society of Laboratory Medicine and is the Chaorman of the IFCC-IOF Committee for bone markers. He is also member of the Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Muskuloskeletal Disesaes (ESCEO) and of the Belgian Bone Club.He is member of the scientific advisory board of the International Osteoporosis Foundation (IOF) and ESCEO as well as member of various Societies of Clinical chemistry, Nephrology and Endocrinology. Professor Cavalier has also published more than 250 scientific papers in Journals indexed on Pubmed and has written 6 books or chapter books.
Etienne Cavalier is now Professor of Clinical Chemistry at the University of Liege and Head of the Department of Clinical Chemistry of the University Hospital of Liege (CHU de Liège).
His current research topics are bones markers, vitamin D, PTH, vascular calcification markers, markers of acute kidney diseases, glomerular filtration rate (estimation, biomarkers), markers of frailty and sarcopenia, LCMS/MS methods for steroids and peptides quantification.
Etienne Cavalier is the actual President of the Royal Belgian Society of Laboratory Medicine and is the Chaorman of the IFCC-IOF Committee for bone markers. He is also member of the Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Muskuloskeletal Disesaes (ESCEO) and of the Belgian Bone Club.He is member of the scientific advisory board of the International Osteoporosis Foundation (IOF) and ESCEO as well as member of various Societies of Clinical chemistry, Nephrology and Endocrinology. Professor Cavalier has also published more than 250 scientific papers in Journals indexed on Pubmed and has written 6 books or chapter books.
Pr. René Rizzoli
Dr. René Rizzoli is an internist and endocrinologist, with a subspecialty focus on metabolic bone diseases, osteoporosis and disorders of mineral metabolism. He has been trained in both basic research and clinical care in Berne, Geneva and at the National Institutes of Health in Bethesda Maryland. He is presently emeritus professor of medicine at the Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland, where he used to be the head of the division of bone diseases and the chair of the department of geriatrics. Dr. Rizzoli is the former chairman of the Committee of Scientific Advisors of the International Osteoporosis Foundation, of which he is now the treasurer. He is the chairman of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and co-chairing the scientific program committee of the annual IOF-ESCEO congress. He is involved in both basic and clinical research projects investigating hormone action, regulation of bone growth, pathophysiology of osteoporosis and of calcium and phosphate homeostasis disorders, and the role of nutrition, calcium, protein, bisphosphonates, selective estrogen modulators, parathyroid hormone, denosumab and strontium ranelate in the prevention and treatment of osteoporosis. Dr. Rizzoli has received numerous international awards. He is the author of more than 900 scientific articles, editor-in-chief of Calcified Tissue International and Musculoskeletal Research and associate editor of Osteoporosis International.
Pr. Charlotte Beaudart
Professor Charlotte Beaudart obtained her PhD in Public Health, Epidemiology and Health Economics in the University of Liège, Belgium in 2016. She obtained a FNRS fellowship for her doctoral research. In 2018, she received the prestigious ESCEO-IOF-Herbert Fleisch Medal. She is appointed as Assistant Professor (Chargée de Cours adjoint) at the Faculty of Medicine, University of Liège, Liège, Belgium.
She is currently working as Scientific Coordinator (part time) in CHU Liège Belgium and as postdoctoral researcher in Maastricht University, The Netherlands.
With an H-index of 26, she authored more than 100 scientific papers.
Her main field of expertise is sarcopenia, systematic reviews, meta-analyses, network meta-analyses, development/translation/validation of scales, patient's preferences studies, etc.
Professor Charlotte Beaudart is considered as one of the leading experts, in the world, in the field of the assessment of quality of life in musculoskeletal diseases.
She is currently working as Scientific Coordinator (part time) in CHU Liège Belgium and as postdoctoral researcher in Maastricht University, The Netherlands.
With an H-index of 26, she authored more than 100 scientific papers.
Her main field of expertise is sarcopenia, systematic reviews, meta-analyses, network meta-analyses, development/translation/validation of scales, patient's preferences studies, etc.
Professor Charlotte Beaudart is considered as one of the leading experts, in the world, in the field of the assessment of quality of life in musculoskeletal diseases.
Pharm. Isabelle Mourad
Isabelle Mourad was graduated as a Master in Pharmaceutical Sciences from the University of Liege in 1994. During more than 20 years, she has been closely involved in the pharmaceutical business. She has developed quality procedures and creative approaches to promote patients' engagement and empowerement, focusing on strategies improving therapeutic adherence in chronic disorders including musculoskeletal diseases.
Pr. Olivier Bruyère
Olivier Bruyère, Ph.D., is currently Professor of Clinical Epidemiology in the Department of Public Health Sciences and of Geriatric Rehabilitation in the Department of Rehabilitation and Sport Sciences of the University of Liège in Belgium. He is head of the Research Unit in Public Health, Epidemiology and Health Economics in this University. Professor Bruyère is the Chief Executive Officer of the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), President of the Belgian Ageing Muscle Society (BAMS), General Secretary of the Belgian Bone Club (BBC), member of the Scientific Advisory Board of the International Osteoporosis Foundation (IOF) as well as member of the Group for the Respect of Ethics and Excellence in Sciences (GREES). He also works as expert for the French Agency for Food, Environmental and Occupational Health & Safety (ANSES). His main fields of interest are prevention, rehabilitation and pharmaco-epidemiology related to geriatric or rheumatic conditions. Besides being Editor-in-chief of the journal “The Archives of Public Health”, he is Executive Editor of “Aging Clinical and Experimental Research”, Associate Editor of “BMC Musculoskeletal Disorders” as well as on the editorial board of various journals. He is author of more than 250 international scientific publications and book chapters.
Phys. Valérie Berchoux
Valérie Berchoux is a rehabilitation specialist currently involved in the management of geriatric and musculoskeletal disorders. She has developed over the last 20 years an important network involving clinicians, scientists and academics active in the field of bone, cartilage and muscle diseases. She is also working in close relationship with insurance companies. Valérie Berchoux has good experience in the clinical use and the interpretation of biologic markers related to musculoskeletal diseases.
Dr. Julien Guiot
Julien GUIOT was born in Liege (Belgium) in 1984. He graduated as Master in Medical sciences in 2009 and Advanced Master Respiratory medicine in 2015 from the University of Liege (Belgium). In 2017, he obtained his PhD thesis in medical science at the University of Liege.
Julien GUIOT is now Assistant lecturer at the University of Liege and Head of clinics in the Department of Respiratory Medicine of the University Hospital of Liege (CHU de Liège).
His current research topics are interstitial and vascular lung diseases, lung biomarkers, COVID-19, AI-based medical tool, Radiomics and extracellular vesicles. He his particularly involved in translational research and the development of new targeted pathways in the field of interstitial and vascular lung diseases.
Julien GUIOT is actually member of the Belgian respiratory Society and the European Respiratory society. He is member of the scientific advisory board of various Societies of pulmonary medicine. Julien GUIOT has also published more than 100 scientific papers in Journals indexed on Pubmed.
Julien GUIOT is now Assistant lecturer at the University of Liege and Head of clinics in the Department of Respiratory Medicine of the University Hospital of Liege (CHU de Liège).
His current research topics are interstitial and vascular lung diseases, lung biomarkers, COVID-19, AI-based medical tool, Radiomics and extracellular vesicles. He his particularly involved in translational research and the development of new targeted pathways in the field of interstitial and vascular lung diseases.
Julien GUIOT is actually member of the Belgian respiratory Society and the European Respiratory society. He is member of the scientific advisory board of various Societies of pulmonary medicine. Julien GUIOT has also published more than 100 scientific papers in Journals indexed on Pubmed.